Pharmaceuticals North America (NAFTA) Industry Guide 2014-2023

Pharmaceuticals North America (NAFTA) Industry Guide 2014-2023

  • June 2020 •
  • 88 pages •
  • Report ID: 4939905 •
  • Format: PDF
Pharmaceuticals North America (NAFTA) Industry Guide 2014-2023

Summary
The NAFTA Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the NAFTA pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights
- The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The pharmaceuticals industry within the NAFTA countries had a total market value of $438.4 billion in 2019.The US was the fastest growing country, with a CAGR of 3.4% over the 2015-19 period.
- Within the pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $409.4 billion in 2019. This was followed by Canada and Mexico, with a value of $23.8 and $5.3 billion, respectively.
- The US is expected to lead the pharmaceuticals industry in the NAFTA bloc, with a value of $417.2 billion in 2024, followed by Canada and Mexico with expected values of $26.8 and $5.5 billion, respectively.

Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ NAFTA operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA pharmaceuticals market with five year forecasts
- Compares data from the US, Canada and Mexico, alongside individual chapters on each country

Reasons to Buy

- What was the size of the NAFTA pharmaceuticals market by value in 2019?
- What will be the size of the NAFTA pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the NAFTA pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the NAFTA pharmaceuticals market?
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.